Cantech Holding Inc BSSP
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $0.00
- Day Range
- $0.00–0.00
- 52-Week Range
- $0.00–0.00
- Bid/Ask
- $0.00 / $0.00
- Market Cap
- $371.89
- Volume/Avg
- 1.9 Mil / 1.8 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- —
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Cantech Holding Inc is a development stage immunotherapeutic-based technology company. Principally, it is focused on commercialization of its proprietary proteins for the treatment of cancer and various infectious diseases. Its Irreversible Pepsine Fraction (IPF) is a therapeutic platform technology that can be used to facilitate varieties of applications. The company’s product consists of IMMUNE-THERAPEUTIC PROTEIN which is a therapeutic protein isolated from porsine pepsin and is irreversible, modified, and fractionated to the sequence IPF.
- Sector
- Healthcare
- Industry
- Biotechnology
- Stock Style Box
- —
- Total Number of Employees
- 1
- Website
- http://www.cantechholding.com
Valuation
Metric
|
BSSP
|
---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | — |
Price/Cash Flow | — |
Price/Earnings
No chart available
Financial Strength
Metric
|
BSSP
|
---|---|
Quick Ratio | 0.00 |
Current Ratio | 0.00 |
Interest Coverage | −2.35 |
Quick Ratio
BSSP
Profitability
Metric
|
BSSP
|
---|---|
Return on Assets (Normalized) | −2,927.99% |
Return on Equity (Normalized) | — |
Return on Invested Capital (Normalized) | — |
Return on Assets
BSSP
Biotechnology Industry Comparables
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
---|---|---|---|---|---|
NVO
| Novo Nordisk A/S ADR | Mmxfbkbzxg | Lzk | $570.1 Bil | |
VRTX
| Vertex Pharmaceuticals Inc | Mzlfjxcz | Psppj | $108.0 Bil | |
REGN
| Regeneron Pharmaceuticals Inc | Cwnylfsw | Ngnnc | $105.6 Bil | |
MRNA
| Moderna Inc | Wwczpqk | Qyxvr | $40.8 Bil | |
ARGX
| argenx SE ADR | Rylfmnd | Bwd | $23.5 Bil | |
BNTX
| BioNTech SE ADR | Mmrjwgglc | Skkb | $21.9 Bil | |
ALNY
| Alnylam Pharmaceuticals Inc | Hnnhdngxw | Xwlxvd | $18.8 Bil | |
BMRN
| Biomarin Pharmaceutical Inc | Zbhlbqh | Pqmqs | $16.5 Bil | |
RPRX
| Royalty Pharma PLC Class A | Hgjhzphm | Fznzdn | $13.6 Bil | |
INCY
| Incyte Corp | Jgblpzdm | Vkftvvr | $12.8 Bil |